1. © Copyright 2002 Frost & Sullivan. All Rights Reserved. U.S. Radiopharmaceuticals Markets Novel Radioisotopes Revitalize Marketplace “The introduction of new, novel radioisotopes and their combination with innovative carrier molecules will bolster markets for radiopharmaceuticals. Commercial development of alpha-emitters, for example, will provide radiologists with better tools to target tumor cells and offer new opportunities for pharmaceutical firms.” Medical Imaging Analyst Team Frost & Sullivan

2. © Copyright 2002 Frost & Sullivan. All Rights Reserved. Frost & Sullivan provides: Detailed insights into recent developments and trends Drivers, restraints, challenges, and strategic recommendations Analyst insights into ‘hot topics’ and emerging applications in the radiopharmaceuticals markets Market sizing and competitive analysis Market forecasts and opportunity analysis Quarterly assessments End-user analysis within each report Key Features

3. © Copyright 2002 Frost & Sullivan. All Rights Reserved. Coverage: The United States Proven methodology encompassing extensive primary and secondary data and research Focused information and strategies that cover business and technology issues Credible data and analysis highlighting industry dynamics Precise strategies to help you create winning business plans What We Offer

4. © Copyright 2002 Frost & Sullivan. All Rights Reserved. Current Market Participants Find out how you compare to with the competition Assess current and future drivers and restraints Determine and exploit new market-share opportunities New Entrants Analyze challenges associated with the industry Calculate time scales for strategy implementation Position yourself to capitalize on the unmet needs of the market Investment Community Analyze long-term strategies of companies Determine participants that will outperform the competition Assess attractiveness of investing in the market Who Will Benefit?

5. © Copyright 2002 Frost & Sullivan. All Rights Reserved. Amersham Health Berlex Laboratories, Inc. Boston Life Sciences, Inc. Bracco Diagnostics, Inc. Bristol Meyers Squibb Co. Central Pharmacy Services, Inc. CIS-US, Inc. Corixa Corp. Cytogen Corp. Draximage, Inc. Eastern Isotopes, Inc. Fujisawa Healthcare, Inc. GlaxoSmithKline Immunomedics, Inc. Mallinckrodt, Inc. NeoRX Corp. P.E.T. Net Pharmaceuticals, Inc. Peregrine Pharmaceuticals, Inc. PharmActinium, Inc. Schering AG Syncor International Corp. Key Market Participants

6. © Copyright 2002 Frost & Sullivan. All Rights Reserved. Call toll free 877 G O F ROST (877.463.7876) Fax toll free 888.690.3329 E-mail myfrost@frost.com Visit www.frost.com For More Information